The Effect Of Vitamin D Supplementation On Glycemic Control In Diabetic Patients With Vitamin D Deficiency

Evaluation Of the Effectiveness Of Vitamin D Supplementation On Glycemic Control In Type 2 Diabetic Patients With Vitamin D Deficiency

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015012520788N1

Enrollment

100

Registered

2015-03-04

Start date

2015-02-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus. Diabetes Mellitus

Interventions

Vitamin D, Capsules 50 mg orally, 4 times a month and 2 times in 2 months after.

Treatment - Drugs

Vitamin D, Capsules 50 mg orally, 4 times a month and 2 times in 2 months after

Eligibility

Sex/Gender

All

Age

35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: A Diagnosis Of Type 2 Diabetes; HbA1c Levels Between 7-12%; Serum Vitamin D Levels Less Than 30 ng / ml Exclusion Criteria: Patients With A History Of ESRD; Every Pregnant Patient; The Patient With A Deficiency Or Inadequate Vitamin D; Any Patient With Nephrotic Syndrome; History Of Present Hypercalcemia And Hyperparathyroidism; Sarcoidosis; Lung And Bone Malignancy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1c. Timepoint: Before intervention, three months after the intervention. Method of measurement: HPLC.	—

Secondary

Measure	Time frame
Blood pressure. Timepoint: Before intervention, three months after the intervention. Method of measurement: Mm-Hg using a mercury sphygmomanometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactManouchehr Iranparvar MD

Medical University of Ardabil

M.Iranparvar@arums.ac.ir+98 45 3351 2006

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026